Nitric oxide (NO) is cytoprotective to certain types of neuronal cells. The neuroprotective ability of NO in the retina was reportedly mediated by the cyclic GMP (cGMP) to protein kinase G (PKG) pathway. Cyclic AMP-responsive element binding protein (CREB) plays an essential role in the NO/cGMP/PKG-mediated survival of rat cerebellar granule cells.
Introduction
Nitric oxide (NO) is implicated in both the pro-and anti-apoptotic signaling pathway depending on cell types and conditions. NO at high concentrations induces neuronal cell death by forming cytotoxic peroxynitrite during ischemic injury or neurodegenerative diseases (Beckman and Koppenol, 1996; Dawson and Dawson, 1998; Wink and Mitchell, 1998; Boje., 2004; Kang et al., 2004; Keynes and Garthwaite, 2004; Duncan and Heales, 2005) . At relatively low concentrations, NO protects neuronal cells, such as PC12 rat pheochromocytoma cells, SK-N-BE human neuroblastoma cells, and rat sympathetic neurons (Farinelli et al., 1996; Kim et al., 1999; Ciani et al., 2002a) , from apoptosis. This neuroprotective ability of NO is mediated at least in part by a cyclic GMP (cGMP)/protein kinase G (PKG) pathway (Farinelli et al., 1996; Kim et al., 1997 Kim et al., , 1999 Fiscus, 2002) . NO activates soluble guanylyl cyclase (sGC), an enzyme that catalyzes synthesis of cGMP from GTP. Elevated cGMP levels then activates PKG, which eventually exerts the anti-apoptotic ability through still unidentified mechanisms.
Cyclic AMP-responsive element binding protein (CREB) is a transcription factor that plays an important role in development, memory function, plasticity, and survival of the nervous system (Finkbeiner et al., 1997; Lee et al., 2004) . Upon phosphorylation at Ser-133, which is located within a kinase-inducible domain, CREB forms a stable complex with the CREB binding protein. The formation of this complex facilitates the transcriptional ability of CREB, which regulates expression of a variety of genes. CREB has also been implicated in the anti-apoptotic NO signaling in SK-N-BE human neuroblastoma cells (Ciani et al., 2002a) and rat cerebellar granule cells (Ciani et al., 2002b) . However, involvement of CREB in the NO-induced retinal neuroprotection through the cGMP/PKG pathway is not known.
Nipradilol (3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran)
is an α1-and β-adrenoceptor antagonist (Uchida et al., 1983; Ohira et al., 1985) containing an NO moiety (Okamura et al., 1996; Hayashi et al., 1997) . Although nipradilol was originally developed as a systemic hypotensive agent (Aramaki et al., 1992; Haneda et al., 1995) , it has recently been used locally, as eyedrops, to reduce intraocular pressure by suppressing aqueous humor production at the ciliary epithelium and facilitating increased uveoscleral outflow via the adrenoceptor antagonistic properties. In addition, nipradilol induces vasodilation and acts as a neuroprotectant, which are attributed to its ability to donate NO.
Nipradilol improves the survival rate of purified retinal ganglion cells (RGCs) in culture (Kashiwagi et al., 2002) , and protects rat RGCs from N-methyl-D-aspartate (NMDA)-, ischemic-, or axotomy-induced damage (Mizuno et al., 2001; Nakazawa et al., 2002; Taniai et al., 2002) . Recent reports demonstrated that nipradilol rescued PC12 cells from serum starvation-induced apoptosis by caspase-3 inhibition through the NO/cGMP/PKG pathway and activated the apoptosis-related nuclear factor kappa B (NFκB) in these cells (Ando et al., 2005) . However, the precise mechanism of nipradilol-mediated neuroprotection in retinal cells was not elucidated.
The purpose of this study was to examine the protective ability of the NO donors sodium nitroprusside (SNP) and nipradilol in R28 cells, which are rat retinal glial and neuronal progenitor cells immortalized with the transfection of the adenovirus 12S E1A. The R28 cell line is a useful model for testing the cytoprotective ability of various substances and drugs (Seigel, 1996; Tezel and Wax, 1999; Nakamura et al., 2001; Nakanishi et al., 2006; Mukuno et al., 2004 ). Here we show that SNP and nipradilol rescue R28 cells from serum starvation-induced apoptosis, at least in part, via the cGMP/PKG pathway. We further demonstrate that CREB mediates the anti-apoptotic ability of NO in these cells.
Materials and methods

Reagents
Nipradilol and denitronipradilol (3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-hydroxy-2H-1-benzopyran) were kindly provided by Kowa Co, Ltd. (Nagoya, Japan). These substances were dissolved in 0.1 N hydrochloric acid and further diluted with phosphate buffer to concentrations between Diego, CA, USA) were dissolved in dimethyl sulfoxide (DMSO).
2-phenyl-4,4,5,5,-tetramethylimidazoline-1-oxyl 3-oxide (c-PTIO) (Dojindo, Tokyo, Japan) was dissolved in 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES). 
Cell culture
R28 cells were seeded on glass coverslips at a density of 2×10 5 /cm 2 and grown to 70% confluency in cAMP-free DMEM containing 5 mM glucose supplemented with 10% newborn bovine serum (Life Technologies, Inc. Rockville, MD, USA), as previously described (Seigel, 1996 , Seigel et al., 2000 Wax, 1999, 2000; Barber et al., 2001; Nakamura et al., 2001; Reber et al., 2002; Mukuno et al., 2004) . At the start of each experiment, the cells were rinsed in phosphate buffered saline (PBS) and then incubated for 24 h in fresh serum-fed medium or serum-deprived medium with or without various concentrations of SNP, nipradilol, denitronipradilol, or 100 μM dibutyryl-cGMP. In a different series of experiments, 1.0 μM c-PTIO, an NO scavenger, 20 μM ODQ, an sGC inhibitor, 0.2 μM KT5823, a PKG inhibitor, and their vehicles, DMSO or HEPES, was added to the cell cultures 10 min prior to NO donor treatment.
Apoptosis quantification
The cells were fixed in 1% paraformaldehyde and then subjected to immunocytochemistry against activated caspase-3 in combination with Hoechst nuclear staining, as previously described Nakamura et al., 2001; Mukuno et al., 2004; Nakanishi et al., 2006 Nakamura et al., 2001; Mukuno et al., 2004) .
Similarly, the percentage of CM-1 immunoreactive cells per coverslip was calculated.
Quantification of cGMP
R28 cells were grown to 80% confluence. The initial culture medium was replaced with serum-free medium. One μM SNP or 10 μM nipradilol was added to the medium and the 
Western Immunoblotting
The cells were harvested in the following lysis buffer: 10 mM HEPES, 42 mM KCl, 5 mM MgCl 2 , 0.1 mM EDTA, 0.1 mM EGTA, 10 mM sodium pyrophosphate, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 10 mM benzamidine, 1% Triton, and 1 protease inhibitor tablet/10 ml (Complete Mini, EDTA-free, Roche Diagnostics GmbH, Mannheim, Germany), as previously described Nakamura et al., 2001; Nakanishi et al., 2006) . After centrifugation at 15,000 rpm for 10 min, the supernatant was collected and protein concentrations were calculated using a Bio-Rad DC Protein Assay Kit (Bio-Rad Laboratories). Fifty μg of protein from each sample was subjected to 10% SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes. Following 1 h blocking with 5% non-fat milk in wash buffer (10 mM Tris-Cl [pH 7.2] containing 100 mM NaCl and 0.1% Tween 20; TBST), the membranes were incubated for 1 h at room temperature with primary antibodies against CREB and phospho CREB (Ser133), each diluted at 1:1000. After washing, the membranes were incubated in 1:4000 horseradish peroxidase-conjugated anti-rabbit IgG for 1 h at room temperature. Protein bands were visualized with enhanced chemiluminescence reagents (ECL plus; Amersham, Arlington Heights, IL, USA) and exposed to instant films using an ECL-mini-camera (Amersham). Relative intensities of bands were quantified by densitometric analysis using the NIH image software. Phosphorylation of protein was calculated as the ratio of the level of expression of phospho relative to total CREB content.
Transfections
R28 cells were seeded on glass coverslips and grown to 80% confluency. Following replacement of the initial culture medium with one without antibiotics, the cells were co-transfected with either 1.2 μg pCMV-CREB or pCMV-CREB133 and 0.4 μg pZsGreen1-N1 per well in 12-well plates using Lipofectamine TM 2000, according to the manufacturer's recommendations. pCMV-CREB is a parental vector with a cytomegalovirus promoter, which expresses the human wild-type (WT) CREB protein and used as a control, whereas pCMV-CREB133 is a vector containing the CREB133 (CR133) construct, a mutant CREB defective of phosphorylation at Ser-133 (Amorino et al., 2003) . pZsGreen1-N1 is a reporter plasmid expressing ZsGreen1 Zoanthus sp. fluorescent protein (Matz et al., 1999) .
After a 24 h incubation period, the cells were deprived of serum and incubated for an additional 24 h with or without 1.0 μM SNP, followed by CM-1 immunohistochemistry, as in the previous experiments. Cells were viewed using X 20 objective of a fluorescence microscope (Keyence, Tokyo). Five visual fields under fluorescence microscope were randomly sampled from each coverslip, and the total number of green-fluorescent cells, which represented the successfully transfected cells, and the number of CM-1 immunoreactive cells in each field was counted. The ratio of cells co-expressing ZsGreen and CM-1 relative to those expressing ZsGreen fluorescence was calculated. These experiments were done in triplicate and repeated twice.
Statistic analyses
ANOVA with Bonferroni/Dunn test (StatView Software, SAS Institute Inc.) was used for statistical comparisons. A P-value of < 0.05 was considered significant.
Results
Dose-dependent anti-apoptotic effects of SNP and nipradilol in R28 cells
To test whether NO exerts an anti-apoptotic effect in R28 cells, they were deprived of serum for 24 h with or without various concentrations of SNP or nipradilol. Hoechst nuclear staining and activated caspase-3 immunostaining confirmed that 24 h serum deprivation induced apoptosis in R28 cells, as previously reported (Seigel, 1996; Tezel and Wax, 1999; Nakamura et al., 2001; Mukuno et al., 2004) 3A ). The cytoprotective effect of nipradilol was also blocked by c-PTIO (P < 0.001; data not shown). These results indicate that NO donation is essential for the SNP-and nipradilol-induced cytoprotection of R28 cells.
Cytoprotection of R28 cells by NO donors via the sGC/cGMP/PKG cascade
Inhibitors to sGC, cGMP, and PKG were used to determine whether the NO-induced cytoprotective effects of SNP and nipradilol are mediated by this pathway. Twenty μM ODQ, an sGC inhibitor, or 0.2 μM KT5823, a PKG inhibitor, was added to the serum-free media 10 min prior to treatment with 1.0 μM SNP or 10 μM nipradilol.
ODQ significantly attenuated the cytoprotective effect of SNP (P < 0.02), whereas ODQ alone did not change the number of apoptotic cells (P = 0.74; Figs. 1F and 3B) . Similarly, the cytoprotection afforded by SNP was negated by KT5823 (P < 0.001), whereas KT5823 alone had no influence on R28 cell viability (P = 0.33; Figs. 1G and 3C ). The cytoprotective effect of nipradilol was also reduced by ODQ and KT5823 treatment (P < 0.001 and P < 0.02, respectively; data not shown).
Dibutyryl-cGMP, a membrane-permeable cGMP analog, was used to evaluate whether cGMP enhances R28 cell survival. As shown in Fig. 1H , addition of 100 μM dibutyryl-cGMP into the serum-free media significantly reduced the pyknotic as well as the activated caspase-3 immunoreactive R28 cells (P < 0.001; data not shown). These results demonstrated that the sGC/cGMP/PKG cascade is involved in the NO-induced cytoprotection of R28 cells.
Elevation of cGMP levels in R28 cells induced by SNP and nipradilol
To confirm if SNP or nipradilol increases cGMP levels in R28 cells, cytoplasmic cGMP concentrations were quantified. Following a 3 h incubation in serum-free medium, R28 cells were treated with 1.0 μM SNP or 10 μM nipradilol for specific time periods then lysed. Whole cell lysates were subjected to ELISA. cGMP levels were transiently, but significantly, elevated 5 min after addition of SNP ( Fig. 4A ; P < 0.01) and 20 min after addition of nipradilol ( Fig. 4B ; P = 0.036).
NO/cGMP/PKG-dependent CREB phosphorylation in R28 cells induced by SNP and nipradilol
A previous study demonstrated that CREB was essential in the cGMP/PKG-mediated anti-apoptotic activity of NO in rat cerebellar granule cells (Ciani et al., 2002b) . To evaluate the involvement of CREB in the NO signaling pathway in R28 cells, CREB phosphorylation was quantified after treatment with SNP or nipradilol. Culture medium was replaced by serum-free medium 3 h before cell harvest. Cells were incubated with 1.0 μM SNP or 10 μM nipradilol for the indicated time periods, and 50 μg portions of whole cell lysates were electrophoresed and probed for total and phospho CREB (Ser-133). The ratio of phospho relative to total CREB content was densitometrically quantified. CREB phosphorylation was significantly increased 10 min after the addition of SNP ( Fig. 5A ; P = 0.024) and 30 min after the addition of nipradilol ( Fig. 5B ; P = 0.013). This demonstrates that SNP and nipradilol activates CREB in R28 cells.
To test whether SNP-and nipradilol-stimulated CREB phosphorylation is dependent on the NO/sGC/PKG pathway, phosphorylation of CREB was quantified by western blotting after denitronipradilol. As shown in Fig. 6A , denitronipradilol had no significant effect on CREB phosphorylation at any time period (P = 0.638).
In a different series of experiments, 20 μM ODQ or 0.2 μM KT5823 was added to the R28 cell culture 10 min prior to 1.0 μM SNP treatment for 10 min. Both ODQ and KT5823
significantly attenuated the effect of SNP on CREB phosphorylation ( Fig. 6B ; P=0.023 and 0.009, respectively). These results indicate that CREB phosphorylation induced by the NO in the R28 cells was sGC/cGMP/PKG-dependent.
CREB phosphorylation as an essential event in the anti-apoptotic signaling cascade of SNP in R28 cells
A dominant negative inhibition experiment was performed to confirm the involvement of CREB phosphorylation in the NO-induced anti-apoptotic effect. R28 cells were grown for 24 h on glass coverslips, which were placed onto 12-well plates, then co-transfected with pZsGreen1-N1 reporter vector (0.4 μg/ml medium) and pCMV-CREB (1.2 μg/ml medium) or pCMV-CREB133 (1.2 μg/ml medium) 24 h prior to SNP treatment. The cells were then incubated for an additional 24 h in serum-free medium with or without 1.0 μM SNP, followed by Hoechst staining and activated caspase-3 immunostaining, as described above. About 
Discussion
The present study clearly demonstrated that relatively low concentrations of SNP and nipradilol protect R28 cells from serum deprivation-induced apoptosis, and that this cytoprotection is mediated, at least in part, by CREB phosphorylation through the sGC/cGMP/PKG pathway. Since the cytoprotective ability was abolished by an NO scavenger and by removal of the NO moiety from a nipradilol molecule, it is evident that this intracellular anti-apoptotic cascade was triggered by NO donation (Fig. 8) .
On the other hand, the NO donors induced apoptosis at concentrations two to three decimal-orders higher than that optimal for cytoprotection. This concentration-dependent dual activity of NO donors in terms of cell survival and death verifies previous reports. As mentioned earlier, excess amounts of NO molecules react with superoxide anions generating highly reactive peroxynitrite molecules that damage the lipid cellular membrane and eventually lead to apoptotic and necrotic cell death (Beckman and Koppenol, 1996; Dawson and Dawson, 1998; Wink and Mitchell, 1998; Fiscus, 2002; Boje, 2004; Kang et al., 2004; Keynes and Garthwaite, 2004; Duncan and Heales, 2005; Taguchi et al., 2006) . In addition, excess NO is associated with cytotoxicity by inhibiting mitochondrial energy production (Wink and Mitchell, 1998) . Thus, whether NO induces neuroprotection or neurotoxicity depends largely on the cell type and on the intracellular and extracellular milieu (Beckman and Koppenol, 1996; Wink and Mitchell, 1998; Fiscus et al., 2002; Keynes and Garthwaite, 2004) .
Although the elevation of intracellular cGMP and phosphorylation of CREB induced by SNP and nipradilol were transient, the rescue effect was prolonged. This is not surprising since once the intracellular signaling cascade is initiated it is considerably amplified. Furthermore, CREB is a transcription factor that can regulate the expression of a number of genes. Thus, a transient increase in intracellular cGMP levels is sufficient for initiating the anti-apoptotic cascade, which leads to a substantial degree of cell survival. Our results showed that the increase in intracellular cGMP and phosphorylation of CREB was induced earlier with SNP than with nipradilol. This could be explained by the fact that SNP releases NO rapidly and spontaneously, whereas an intracellular enzymatic catalytic step is required by nipradilol before releasing NO.
Caspase-3, a key mediator of apoptosis in mammalian cells, is cleaved by caspase-8 or caspase-9 for activation. Cytochrome c released from the mitochondria forms the apoptosome, which activates caspase-9. Bcl-2 and phosphorylated Bcl-associated death promoter prevents this caspase-cascade by inhibiting the Bax-regulated cytochrome c release from the mitochondria. NO is known to enhance cellular survival by regulating this caspase-Bcl family interaction at several points. NO can directly inactivate caspase-3 by S-nytrosylation at cysteine residues thus preventing apoptosis of cerebrocortical neurons and hepatocytes (Kim et al., 1997; Tenneti et al., 1997) . In addition, NO-stimulated cGMP production inhibits apoptosis by preventing cytochrome c release, increasing Bcl-2 expression, and decreasing Bax expression in PC12 cells (Ando et al., 2005) , cerebellar granule cells (Ciani et al., 2002b ) , and dorsal root ganglion cells (Thippeswamy et al., 2001) , respectively. Although the present study documented that reduced caspase-3 activation by SNP and nipradilol was cGMP/PKG-dependent in R28 cells, it does not entirely exclude direct inhibition of caspase-3 activity by NO.
This study showed for the first time that CREB phosphorylation is a crucial step in the NO-mediated cGMP/PKG-dependent anti-apoptotic pathway in retinal neuro-glial progenitor cells. Previous studies demonstrated that expression of dominant negative forms of CREB interferes with pro-survival signaling of growth factors (Riccio et al., 1999) and that CREB null mice exhibited extensive apoptotic death of dorsal root ganglion sensory neurons and sympathetic neurons . Thus, our study provides additional evidence that CREB is a convergent point in the neuronal survival-signaling pathway involving various stimuli including NO. Several reports demonstrated that CREB phosphorylation was induced in the RGC layer after exposure to constant light, Ca + -channel activation, and NMDA stimulation (Yoshida et al., 1995 (Yoshida et al., , 1998 Isenoumi et al., 2004) . The enhanced phosphorylation of CREB may be a form of self-defense neuroprotective mechanism employed by the RGCs. However, the overall effect of the intrinsic CREB-dependent neuroprotective mechanism may be too small for the RGCs to overcome insults, particularly in instances of prolonged and repeated exposure. Augmenting this neuroprotective mechanism is therefore necessary and pharmaceutical intervention provides a promising option. These drugs may therefore cease or considerably retard the progression of neurodegenerative disorders, such as glaucomatous optic neuropathy and diabetic retinopathy. Both retinal diseases are known to share common pathologies, which include altered glial function, microglial activation, impaired glutamate metabolism, and the eventual increase in RGC apoptosis (Quigley et al., 1995; Kerrigan et al., 1997; Dkhissi et al., 1999; Tatton et al., 2001; McKinnon et al., 2002; Barber, 2003; Kanamori et al., 2004) .
There is accumulating evidence that nipradilol not only reduces intraocular pressure via its adrenoceptor antagonistic property but also promotes RGC survival in vitro and in vivo via the NO donation as mentioned earlier (Mizuno et al., 2001; Kashiwagi et al., 2002; Nakazawa et al., 2002; Taniai et al., 2002) . The present study demonstrated the ability of nipradilol to activate CREB in retinal neuro-glial progenitor cells. This may serve as an important base for further evaluation of the role of nipradilol as a potential retinal neuroprotectant in vivo. It was reported that in monkeys, pharmacologically effective concentrations of topically instilled radiolabeled-nipradilol reaches the retina via the periocular route (Mizuno et al. 2001 (Mizuno et al. , 2002 . Further studies for a more effective method of drug delivery to the retina and optic nerve head, particularly of nipradilol and other NO donors, are therefore necessary. Identical statistical values were used for the comparisons of the CM-1 immunoreactive cell ratios. The descriptions, however, were omitted for clarity. In contrast, approximately 13% of the cells transfected with CREB 133 mutant were immunoreactive to activated caspase 3 regardless of SNP treatment (P = 0.689). *, P < 0.0001; n.s., not significant. 
Figure legends
